Items where authors include "Anderson, N."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Kyte, D., Fletcher, B., Horton, M. orcid.org/0000-0002-6675-7335 et al. (12 more authors) (2025) Development, Rasch analysis and validation of the kidney symptom burden questionnaire (KSB-Q). Clinical Kidney Journal, 18 (5). sfaf112. ISSN 2048-8505
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370
Crossnohere, N.L. orcid.org/0000-0002-2811-1330, Anderson, N., Baumhauer, J. orcid.org/0000-0003-2142-7778 et al. (15 more authors) (2024) A framework for implementing patient-reported outcomes in clinical care: the PROTEUS-practice guide. Nature Medicine, 30. pp. 1519-1520. ISSN 1078-8956
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Anderson, N., Habib, B., Harris, S. et al. (2 more authors) (2022) Racial capitalism and the school geography curriculum. Teaching Geography, 2022 (Spring). pp. 15-18. ISSN 0305-8018
Conference or Workshop Item
Crossnohere, N., Anderson, N., Baumhauer, J. et al. (15 more authors) (2024) HSD71 Implementing Patient-Reported Outcomes in Clinical Practice: The PROTEUS-Practice Framework & Guide. In: ISPOR 2024, 05-08 May 2024, Atlanta, USA.
Proceedings Paper
Kunkler, I., Russell, N., Anderson, N. et al. (21 more authors) (2025) Abstract GS2-03: Does postmastectomy radiotherapy in 'intermediate-risk' breast cancer impact overall survival? 10 year results of the BIG 2-04 MRC SUPREMO randomised trial: on behalf of the SUPREMO trial investigators. In: Clinical Cancer Research. San Antonio Breast Cancer Symposium 2024, 10-13 Dec 2024, Texas, USA. American Association for Cancer Research (AACR) .